lilly retatrutide trial Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical VisualAbstract: Retatrutide reduces body weight

Brand-name medications require the separate $99/mo Shed Membership

doi: 10.1111/imr.12170 46 XueSWasserfallCHParkerMBruskoTMMcGrailSMcGrailKet al

The 12mg cohort achieved the highest mean body weight reduction at -24.2% exceeding all published results for semaglutide (approximately -16% in the STEP trials) and tirzepatide (approximately -22.5% in SURMOUNT-1) at their respective maximum doses

Its something I think we as clinicians need to educate our patients about especially females of childbearing age

Tirzepatide is administered once a week via a subcutaneous injection

We are the leaders in weight loss and prevention of lifestyle diseases